Retractable Technologies (NYSE:RVP) & Anika Therapeutics (NASDAQ:ANIK) Head to Head Contrast

Anika Therapeutics (NASDAQ:ANIK) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Valuation & Earnings

This table compares Anika Therapeutics and Retractable Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anika Therapeutics	$119.91 million	1.70	-$82.67 million	($3.85)	-3.74
Retractable Technologies	$33.05 million	0.68	-$7.01 million	($0.41)	-1.83

Retractable Technologies has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 7.9% of Anika Therapeutics shares are held by company insiders. Comparatively, 57.1% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Anika Therapeutics and Retractable Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anika Therapeutics	0	1	1	1	3.00
Retractable Technologies	0	0	0	0	0.00

Anika Therapeutics presently has a consensus price target of $21.67, indicating a potential upside of 50.67%. Given Anika Therapeutics’ stronger consensus rating and higher possible upside, analysts clearly believe Anika Therapeutics is more favorable than Retractable Technologies.

Profitability

This table compares Anika Therapeutics and Retractable Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anika Therapeutics	-59.40%	-2.22%	-1.75%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Risk and Volatility

Anika Therapeutics has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.28, meaning that its stock price is 128% more volatile than the S&P 500.

Summary

Anika Therapeutics beats Retractable Technologies on 9 of the 15 factors compared between the two stocks.

About Anika Therapeutics

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company’s joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.